Biology of tissue inhibitor of metalloproteinase 3 (TIMP3), and its therapeutic implications in cardiovascular pathology

D Fan, Z Kassiri - Frontiers in Physiology, 2020 - frontiersin.org
Tissue inhibitor of metalloproteinase 3 (TIMP3) is unique among the four TIMPs due to its
extracellular matrix (ECM)-binding property and broad range of inhibitory substrates that …

The microRNA in ventricular remodeling: the miR-30 family

X Zhang, S Dong, Q Jia, A Zhang, Y Li, Y Zhu… - Bioscience …, 2019 - portlandpress.com
Ventricular remodeling (VR) is a complex pathological process of cardiomyocyte apoptosis,
cardiac hypertrophy, and myocardial fibrosis, which is often caused by various …

Insight into the role of the PI3K/Akt pathway in ischemic injury and post-infarct left ventricular remodeling in normal and diabetic heart

B Walkowski, M Kleibert, M Majka, M Wojciechowska - Cells, 2022 - mdpi.com
Despite the significant decline in mortality, cardiovascular diseases are still the leading
cause of death worldwide. Among them, myocardial infarction (MI) seems to be the most …

The regulation of necroptosis and perspectives for the development of new drugs preventing ischemic/reperfusion of cardiac injury

LN Maslov, SV Popov, NV Naryzhnaya… - Apoptosis, 2022 - Springer
In the last 10 years, mortality from acute myocardial infarction (AMI) has not significantly
decreased. This situation is associated with the absence in clinical practice of highly …

Epigenetics-based therapeutics for myocardial fibrosis

X Li, Y Yang, S Chen, J Zhou, J Li, Y Cheng - Life sciences, 2021 - Elsevier
Myocardial fibrosis (MF) is a reactive remodeling process in response to myocardial injury. It
is mainly manifested by the proliferation of cardiac muscle fibroblasts and secreting …

MicroRNAs in acute ST elevation myocardial infarction—a new tool for diagnosis and prognosis: therapeutic implications

AI Scărlătescu, MM Micheu, NM Popa-Fotea… - International journal of …, 2021 - mdpi.com
Despite diagnostic and therapeutic advances, coronary artery disease and especially its
extreme manifestation, ST elevation myocardial infarction (STEMI), remain the leading …

Exosomes: from potential culprits to new therapeutic promise in the setting of cardiac fibrosis

R Tikhomirov, B Reilly-O'Donnell, F Catapano… - Cells, 2020 - mdpi.com
Fibrosis is a significant global health problem associated with many inflammatory and
degenerative diseases affecting multiple organs, individually or simultaneously. Fibrosis …

Mapping the Minnesota living with heart failure questionnaire (MLHFQ) to EQ-5D-5L in patients with heart failure

S Kularatna, S Senanayake, G Chen… - Health and Quality of Life …, 2020 - Springer
Background Mapping algorithms can be used to convert scores from a non-preference
based instrument to health state utilities. The objective of this study was to develop mapping …

[HTML][HTML] Cardiac microRNAs: diagnostic and therapeutic potential

A Kabłak-Ziembicka, R Badacz, M Okarski… - Archives of Medical …, 2023 - ncbi.nlm.nih.gov
MicroRNAs are small non-coding post-translational biomolecules which, when expressed,
modify their target genes. It is estimated that microRNAs regulate production of …

Reducing cardiac injury during ST-elevation myocardial infarction: a reasoned approach to a multitarget therapeutic strategy

A Bellis, G Di Gioia, C Mauro, C Mancusi… - Journal of Clinical …, 2021 - mdpi.com
The significant reduction in 'ischemic time'through capillary diffusion of primary
percutaneous intervention (pPCI) has rendered myocardial-ischemia reperfusion injury …